ResearcherUniversitätsklinikum Knappschaftskrankenhaus BochumActive in the last 2 years
Barbara Sitek
Matched on ORCID iD 0009-0002-1658-7953; OpenAlex author ID A5063961467. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. Co-author DOI 10.1186/s13148-024-01623-z↗
- Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. Co-author DOI 10.2967/jnumed.120.256776↗
- Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of… Co-author DOI 10.1007/s00428-017-2114-2↗
- Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of M… Last author DOI 10.1074/mcp.m115.054585↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sven‐Thorsten Liffers · 1 shared paper, 2024 · strength 0.17
- Diana Behrens · 1 shared paper, 2024 · strength 0.17
- Marija Trajkovic‐Arsic · 1 shared paper, 2024 · strength 0.17
- Steven A. Johnsen · 1 shared paper, 2024 · strength 0.17
- Laura Godfrey · 1 shared paper, 2024 · strength 0.17
- Rita Teresa Lawlor · 1 shared paper, 2024 · strength 0.17
- Jens Thomas Siveke · 1 shared paper, 2024 · strength 0.17
- Aldo Scarpa Scarpa · 1 shared paper, 2024 · strength 0.17
- Bence Sipos · 2 shared papers, 2016–2021 · strength 0.16
- Juliet Padden · 2 shared papers, 2016–2017 · strength 0.11
- Paper Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ducta… DOI 10.1007/s00428-017-2114-2↗
- Paper Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDA… DOI 10.1074/mcp.m115.054585↗
- Julia Kälsch · 2 shared papers, 2016–2017 · strength 0.11
- Paper Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ducta… DOI 10.1007/s00428-017-2114-2↗
- Paper Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDA… DOI 10.1074/mcp.m115.054585↗
- Jan Grimm · 1 shared paper, 2021 · strength 0.11
- Kelly E. Henry · 1 shared paper, 2021 · strength 0.11
- Susanne Klein‐Scory · 1 shared paper, 2021 · strength 0.11
- Jason Stuart Lewis · 1 shared paper, 2021 · strength 0.11
- Holger Kalthoff · 1 shared paper, 2021 · strength 0.11
- Hideo Andreas Baba · 1 shared paper, 2017 · strength 0.06
- Hideo Baba · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.